Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-14, Stock:LLY, The news for the past five days is as follows:
2020-09-04: NEWS1: Lilly (LLY) Gets FDA Approval for Higher Doses of Trulicity.NEWS2: The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study.
2020-09-08: NEWS1: COVID-19 vaccine safety pledge will make 'huge difference': Doctor.NEWS2: S.Korea's Celltrion to begin commercial production of COVID-19 antibody drug.
2020-09-09: NEWS1: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS2: Regeneron expects to report biomarker data for COVID-19 therapy by September end.NEWS3: 2 Coronavirus Treatment Stocks to Buy Right Now.NEWS4: Lilly Announces Leadership Changes.
2020-09-10: NEWS1: Lilly Announces Webcast to Discuss ESMO 2020 Presentations.NEWS2: Regeneron’s Virus Treatment Has Probably Missed the Bus.NEWS3: Lilly commits Insulin Value Program, featuring $35 copay card, to suite of affordability solutions for people with diabetes.NEWS4: Lilly Oncology to Showcase New Data from Robust Cancer Research Pipeline at ESMO Virtual Congress 2020.
2020-09-11: NEWS1: Lilly to Participate in Cantor Fitzgerald Virtual Global Healthcare Conference.NEWS2: Animal Spirits for Elanco? Pet-Care Company’s Stock Is Well Positioned for Gains..NEWS3: Antibody therapy developer AbCellera hires banks for U.S. IPO -sources.NEWS4: Lilly to Participate in Morgan Stanley Global Healthcare Conference.NEWS5: U.S. Drug Stocks Look Cheap. Here’s Why, According to One Analyst..NEWS6: It’s Likely Too Late for Regeneron’s Virus Treatment.NEWS7: REYVOW™ (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study.

Answer: Rise